More recent studies suggest that the blood concentration of trimethylamine N-oxide (TMAO), generated from trimethylamine-containing nutrients like dietary choline, rather than that of choline, might influence the risk of cardiovascular events (see Safety)
The FDA approved Wegovy in 2024 specifically to reduce cardiovascular death, heart attack, and stroke risk in this population
Both contain identical tirzepatide molecules but carry different FDA-approved indications which matters significantly for insurance coverage
Promotes Satiety: Acting on the brains appetite centers, it increases feelings of fullness and reduces food intake, which can contribute to weight loss
"Fact Sheet: GLP-1 Pricing Agreement with Novo Nordisk and Eli Lilly." White House Briefing Room
The factor was active at nanomolar concentrations and stimulated incorporation of labeled uridine and thymidine into trichloroacetic-acid-precipitable material, behavior consistent with a small molecule rather than a protein